These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 28653770)

  • 41. N-acetyltransferase 2 acetylator genotype-dependent N-acetylation of 4-aminobiphenyl in cryopreserved human hepatocytes.
    Habil MR; Doll MA; Hein DW
    Pharmacogenet Genomics; 2020 Apr; 30(3):61-65. PubMed ID: 31895247
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors of N-acetyltransferase activity: should caffeine phenotyping and NAT2 genotyping be used interchangeably in epidemiological studies?
    Le Marchand L; Sivaraman L; Franke AA; Custer LJ; Wilkens LR; Lau AF; Cooney RV
    Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):449-55. PubMed ID: 8781741
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phenotyping of N-acetyltransferase type 2 by caffeine from uncontrolled dietary exposure.
    Jetter A; Kinzig-Schippers M; Illauer M; Hermann R; Erb K; Borlak J; Wolf H; Smith G; Cascorbi I; Sörgel F; Fuhr U
    Eur J Clin Pharmacol; 2004 Mar; 60(1):17-21. PubMed ID: 14747882
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enzyme kinetic properties of human recombinant arylamine N-acetyltransferase 2 allotypic variants expressed in Escherichia coli.
    Hickman D; Palamanda JR; Unadkat JD; Sim E
    Biochem Pharmacol; 1995 Aug; 50(5):697-703. PubMed ID: 7669073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer.
    Cascorbi I; Brockmöller J; Mrozikiewicz PM; Bauer S; Loddenkemper R; Roots I
    Cancer Res; 1996 Sep; 56(17):3961-6. PubMed ID: 8752164
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acetylator status and N-acetyltransferase 2 gene polymorphisms; phenotype-genotype correlation with the sulfamethazine test.
    Taja-Chayeb L; González-Fierro A; Miguez-Muñoz C; Trejo-Becerril C; Cruz-Hernandez Ede L; Cantu D; Agundez JA; Vidal-Millan S; Gutierrez O; Dueñas-González A
    Pharmacogenet Genomics; 2011 Dec; 21(12):894-901. PubMed ID: 21946899
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Determination and allelic allocation of seven nucleotide transitions within the arylamine N-acetyltransferase gene in the Polish population.
    Mrozikiewicz PM; Cascorbi I; Brockmöller J; Roots I
    Clin Pharmacol Ther; 1996 Apr; 59(4):376-82. PubMed ID: 8612380
    [TBL] [Abstract][Full Text] [Related]  

  • 48. N-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulphasalazine in the treatment of inflammatory bowel disease.
    Chen M; Xia B; Chen B; Guo Q; Li J; Ye M; Hu Z
    Can J Gastroenterol; 2007 Mar; 21(3):155-8. PubMed ID: 17377643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Arylamine N-acetyltransferase (NAT2) genotypes in a Turkish population.
    Aynacioglu AS; Cascorbi I; Mrozikiewicz PM; Roots I
    Pharmacogenetics; 1997 Aug; 7(4):327-31. PubMed ID: 9295061
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical relevance of N-acetyltransferase type 2 (NAT2) genetic polymorphism].
    Furet Y; Bechtel Y; Le Guellec C; Bechtel PR; Autret-Leca E; Paintaud G
    Therapie; 2002; 57(5):427-31. PubMed ID: 12611196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population.
    Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
    Int J Toxicol; 2004; 23(1):25-31. PubMed ID: 15162844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determination of N-acetylation phenotyping in a Greek population using caffeine as a metabolic probe.
    Asprodini EK; Zifa E; Papageorgiou I; Benakis A
    Eur J Drug Metab Pharmacokinet; 1998; 23(4):501-6. PubMed ID: 10323334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acetylation phenotypes and biological variation in a French Caucasian population.
    Pontes ZB; Vincent-Viry M; Gueguen R; Galteau MM; Siest G
    Eur J Clin Chem Clin Biochem; 1993 Feb; 31(2):59-68. PubMed ID: 8467011
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic sclerosis.
    Skretkowicz K; Skretkowicz J; Gawrońska-Szklarz B; Górnik W; Rychlik-Sych M; Sysa-Jedrzejowska A
    Eur J Clin Pharmacol; 2005 Jan; 60(11):773-8. PubMed ID: 15565348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polymorphisms of NAT2 in relation to sulphasalazine-induced agranulocytosis.
    Wadelius M; Stjernberg E; Wiholm BE; Rane A
    Pharmacogenetics; 2000 Feb; 10(1):35-41. PubMed ID: 10739170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic heterogeneity among slow acetylator N-acetyltransferase 2 phenotypes in cryopreserved human hepatocytes.
    Doll MA; Hein DW
    Arch Toxicol; 2017 Jul; 91(7):2655-2661. PubMed ID: 28516247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer.
    Hunter DJ; Hankinson SE; Hough H; Gertig DM; Garcia-Closas M; Spiegelman D; Manson JE; Colditz GA; Willett WC; Speizer FE; Kelsey K
    Carcinogenesis; 1997 Nov; 18(11):2127-32. PubMed ID: 9395212
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of N-acetyltransferase (NAT) in cultured human uroepithelial cells.
    Kloth MT; Gee RL; Messing EM; Swaminathan S
    Carcinogenesis; 1994 Dec; 15(12):2781-7. PubMed ID: 8001235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlation between acetylation phenotype and genotype in Chinese women.
    Zhao B; Seow A; Lee EJ; Lee HP
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):689-92. PubMed ID: 11214777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation of N-acetyltransferase 2 genotype with isoniazid acetylation in Polish tuberculosis patients.
    Zabost A; Brzezińska S; Kozińska M; Błachnio M; Jagodziński J; Zwolska Z; Augustynowicz-Kopeć E
    Biomed Res Int; 2013; 2013():853602. PubMed ID: 24383060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.